PROCEPT BioRobotics Corporation Common Stock

$26.76
USD
Last updated on --.
24h volume304.49K
24h highest27.5690 USD
24h lowest26.1450 USD
24h Price movement+1.67%

PRCT recent prices

24 Hours
+1.67%+$0.439
30 days
+9.82%+$2.435
60 days
+14.53%+$3.455
90 days
+8.73%+$2.115

Key data

Previous close26.3300 USD
Market cap1.50B USD
Volume304.49K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8000 USD
Net income (FY)-102.47M USD
Revenue (FY)322.02M USD
Last report dateApr 30, 2026

About PROCEPT BioRobotics Corporation Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
HeadquartersSAN JOSE
Employees (FY)888.00
Revenue per employee (FY)362.64K USD
Net income per employee (FY)-115.40K USD
Listed onNasdaq
Official website

PRCT conversion tables

PRCTPRCT
USDUSD
0.5 PRCT13.38 USD
1 PRCT26.76 USD
5 PRCT133.84 USD
10 PRCT267.69 USD
USDUSD
PRCTPRCT
0.5 USD0.018678 PRCT
1 USD0.037357 PRCT
5 USD0.18678 PRCT
10 USD0.37357 PRCT

FAQ

PRCT is trading at $26.76, +1.67% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PRCT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PRCT is currently trading at $26.76, +1.67% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PRCT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PRCT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PRCT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PRCT's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
PROCEPT BioRobotics Corporation Common Stock's market cap is currently 1.50B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume304.49K
24h highest27.5690 USD
24h lowest26.1450 USD
24h Price movement+1.67%
PRCTPRCT
USDUSD
Start trade with PRCT Perpetual